Graves' disease is an autoimmune condition causing hyperthyroidism, leading to various symptoms and requiring tailored treatment approaches including medication, radioactive iodine, or surgery.

Graves' disease is the most common cause of autoimmune hyperthyroidism, a condition where the thyroid gland produces too much thyroid hormone [1, 5]. This autoimmune disorder occurs when the body's immune system mistakenly produces antibodies that stimulate the thyroid-stimulating hormone (TSH) receptor on thyroid cells, leading to an overactive thyroid gland [3, 5]. Understanding its symptoms and available treatments is crucial for effective management.

Recognizing the Symptoms of Graves' Disease

The excess thyroid hormones in Graves' disease can affect many body systems, leading to a range of symptoms. Common indicators of hyperthyroidism include a suppressed thyroid-stimulating hormone (TSH) level and markedly elevated free thyroid hormone levels in blood tests [1, 4]. Physically, patients may develop a diffuse enlargement of the thyroid gland, known as a goiter [1].

While many symptoms are typical of an overactive metabolism, some presentations can be less common or even misleading:

General Hyperthyroidism Symptoms: These can include weight loss despite increased appetite, rapid or irregular heartbeat, tremors, anxiety, irritability, heat intolerance, and difficulty sleeping.
Uncommon Skin Manifestations: Severe, worsening itching (pruritus) is a known but uncommon symptom of hyperthyroidism that can sometimes be overlooked [4].
Neuropsychiatric Symptoms: Rarely, Graves' disease may present predominantly with neuropsychiatric symptoms, such as severe, treatment-resistant panic attacks and night terrors, which might initially be misdiagnosed as a primary psychiatric disorder [8].

In severe cases, uncontrolled hyperthyroidism can lead to a life-threatening condition called thyroid storm, characterized by an extreme surge of thyroid hormones that can cause fever, rapid heart rate, confusion, and even coma [1].

Graves' Eye Disease: An Extrathyroidal Manifestation

Beyond the thyroid gland itself, Graves' disease can also affect other parts of the body. Approximately 25% of patients develop an inflammatory condition known as Graves' eye disease (GED), also called thyroid eye disease [3]. This condition affects the orbital soft tissues around the eyes.

Symptoms of GED can range from mild to severe:

Mild Symptoms: About 60% of patients with GED experience fat expansion and inflammation of the levator muscle complex, leading to bulging eyes (proptosis), eyelid retraction, and increased exposure of the globe [3].
Severe Symptoms: Other patients may experience enlargement of one or more of the extraocular muscles, causing conjunctival and eyelid swelling, restricted eye movement resulting in double vision (diplopia), and in critical cases, compression of the optic nerve, which can lead to vision loss [3].

Diagnosing Graves' Disease

Diagnosis typically begins with blood tests to measure thyroid hormone levels (free T3 and T4) and TSH. In Graves' disease, TSH levels are usually suppressed, and free thyroid hormone levels are elevated [1, 4]. The presence of TSH receptor antibodies (TRAbs) further supports the diagnosis [4]. A thyroid scan or scintigraphy, which shows increased uptake in the thyroid gland, can confirm the diagnosis and help differentiate Graves' disease from other causes of hyperthyroidism [4, 8].

Treatment Approaches for Hyperthyroidism

The primary goal of Graves' disease treatment is to reduce the overproduction of thyroid hormones and alleviate symptoms. Treatment options generally include antithyroid medications, radioactive iodine, or surgery [1, 5].

Antithyroid Medications (ATDs): Drugs like methimazole and propylthiouracil (PTU) work by blocking the thyroid gland's ability to produce hormones [1, 4, 5]. PTU may be used during the first trimester of pregnancy, with a switch to methimazole typically recommended after the first 12 weeks [4]. Beta-blockers may also be used to manage symptoms like rapid heart rate and tremors [1].
Radioactive Iodine (RAI) Therapy: This treatment involves taking a dose of radioactive iodine, which is absorbed by the overactive thyroid cells, leading to their destruction and reducing hormone production [1, 5].
Surgery (Total Thyroidectomy): Surgical removal of the entire thyroid gland is a definitive treatment that eradicates hyperthyroidism if all thyroid tissue is removed [5]. While it is the least common treatment for Graves' disease, it may be recommended for patients with persistent thyrotoxicosis despite prolonged medication, severe complications like thyroid storm, or when other treatments are not suitable [1, 2, 5]. Preoperative preparation typically involves antithyroid medications to restore normal thyroid function (euthyroidism) before surgery [5].

When Treatment Becomes Challenging

Managing Graves' disease can sometimes present challenges. Some patients may experience persistent thyrotoxicosis despite prolonged medical treatment [1]. Additionally, Graves' disease can occasionally co-occur with other thyroid conditions, such as Hashimoto's thyroiditis or even papillary thyroid carcinoma, complicating diagnosis and treatment [2, 6]. Rapid changes in thyroid function, such as a conversion between Hashimoto's thyroiditis and Graves' disease, can also pose diagnostic and therapeutic difficulties, underscoring the need for close monitoring [6].

Research continues to explore factors that may influence Graves' disease. For instance, serum 25-hydroxyvitamin D levels have been inversely associated with peripheral thyroid hormone levels in patients with Graves' disease. However, current studies are cross-sectional, meaning no causal link between vitamin D status and thyroid hormone dynamics has been established [7].

Given the varied presentations and potential complexities, a multidisciplinary approach and careful monitoring are essential for individuals with Graves' disease to ensure effective management and improve outcomes.

Sources

[1] Total Thyroidectomy for Severe Thyrotoxicosis in a Young Woman: A Case Report. https://pubmed.ncbi.nlm.nih.gov/42147600/
[2] Spectrum of thyroid disease in a single patient: A case of papillary thyroid carcinoma in a patient with Graves' disease and Hashimoto's thyroiditis. https://pubmed.ncbi.nlm.nih.gov/36188051/
[3] Extrathyroidal Manifestations of Thyroid Disease: Graves Eye Disease. https://pubmed.ncbi.nlm.nih.gov/34243871/
[4] A Pruritic Predicament: An Unusual Presentation of Graves' Disease Complicated by Pregnancy. https://pubmed.ncbi.nlm.nih.gov/42577721/
[5] Surgical considerations for adult Graves' disease: a narrative review of indications, perioperative challenges and postoperative outcomes. https://pubmed.ncbi.nlm.nih.gov/42169504/
[6] Rapid Changes of Thyroid Function in a Young Woman with Autoimmune Thyroid Disease. https://pubmed.ncbi.nlm.nih.gov/30897565/
[7] Association between serum 25-hydroxyvitamin D levels and thyroid hormone profiles in Graves' disease: a retrospective cross-sectional stratified analysis. https://pubmed.ncbi.nlm.nih.gov/42124373/
[8] Graves' Disease Presenting as Refractory Panic Attacks: Diagnostic Clarification Through Thyroid Scintigraphy. https://pubmed.ncbi.nlm.nih.gov/42389036/

This article summarises published research for a general audience. It is not medical advice — talk to a qualified clinician about your own situation. Need help finding one? Browse doctors.